| Literature DB >> 16585579 |
Friederike Berberich-Siebelt1, Ingolf Berberich, Mindaugas Andrulis, Brigitte Santner-Nanan, Mithilesh K Jha, Stefan Klein-Hessling, Anneliese Schimpl, Edgar Serfling.
Abstract
The transcription factor C/EBPbeta transactivates the IL-4 gene in murine T lymphocytes and facilitates Th2 cell responses. In this study, we demonstrate that C/EBPbeta also acts as a repressor of T cell proliferation. By binding to the c-myc promoter(s), C/EBPbeta represses c-Myc expression and, therefore, arrests T cells in the G1 phase of the cell cycle. For C/EBPbeta-mediated repression, the integrity of its N-terminal transactivation domain is essential whereas the central regulatory domain is dispensable. This central regulatory domain is sumoylated in vivo which leads to an alteration of the activity of C/EBPbeta. Whereas sumoylation does not affect the C/EBPbeta-mediated activation of the IL-4 gene, it relieves its repressive effect on c-Myc expression and T cell proliferation. Similar to several other transcription factors, sumoylation redistributes nuclear C/EBPbeta and targets it to pericentric heterochromatin. These results suggest an important role of sumoylation in adjusting the finely tuned balance between proliferation and differentiation in peripheral T cells which is controlled by C/EBPbeta.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16585579 DOI: 10.4049/jimmunol.176.8.4843
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422